Abstract
This cross-sectional study evaluates changes in the rate of germline BRCA testing among patients with ovarian cancer between 2008 and 2018 and analyzes factors associated with testing rates.
Publication types
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Aged
-
Antineoplastic Agents / therapeutic use
-
Cross-Sectional Studies
-
Delayed Diagnosis
-
Early Detection of Cancer
-
Female
-
Genes, Tumor Suppressor
-
Genetic Testing / statistics & numerical data*
-
Humans
-
Insurance, Health*
-
Middle Aged
-
Ovarian Neoplasms* / diagnosis
-
Ovarian Neoplasms* / drug therapy
-
Ovarian Neoplasms* / epidemiology
-
Ovarian Neoplasms* / genetics
-
Practice Patterns, Physicians'